Takeda Pharmaceutical Co., Ltd. (TKPHF)
31.30
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Takeda Pharmaceutical EPS Diluted (Quarterly) : -0.0992 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0992 |
| December 31, 2025 | 0.4198 |
| September 30, 2025 | -0.0507 |
| June 30, 2025 | 0.5411 |
| March 31, 2025 | -0.4288 |
| December 31, 2024 | 0.0957 |
| September 30, 2024 | 0.3831 |
| June 30, 2024 | 0.3847 |
| March 31, 2024 | -0.013 |
| December 31, 2023 | 0.451 |
| September 30, 2023 | -0.2123 |
| June 30, 2023 | 0.4153 |
| March 31, 2023 | 0.1457 |
| December 31, 2022 | 0.5364 |
| September 30, 2022 | 0.2854 |
| June 30, 2022 | 0.5203 |
| March 31, 2022 | -0.0628 |
| December 31, 2021 | 0.3225 |
| September 30, 2021 | 0.2642 |
| June 30, 2021 | 0.7994 |
| March 31, 2021 | 1.180 |
| December 31, 2020 | 0.5607 |
| September 30, 2020 | 0.0242 |
| June 30, 2020 | 0.49 |
| March 31, 2020 | 0.0097 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.1903 |
| September 30, 2019 | 0.4039 |
| June 30, 2019 | 0.0409 |
| March 31, 2019 | -0.1708 |
| December 31, 2018 | 0.4247 |
| September 30, 2018 | 0.5515 |
| June 30, 2018 | 0.9114 |
| March 31, 2018 | -0.6384 |
| December 31, 2017 | 0.767 |
| September 30, 2017 | 0.3215 |
| June 30, 2017 | 1.659 |
| March 31, 2017 | -0.5722 |
| December 31, 2016 | 0.4815 |
| September 30, 2016 | 0.3088 |
| June 30, 2016 | 1.174 |
| March 31, 2016 | -0.371 |
| December 31, 2015 | 0.6177 |
| September 30, 2015 | 0.3087 |
| June 30, 2015 | 0.2563 |
| March 31, 2015 | -2.408 |
| December 31, 2014 | 0.2031 |
| September 30, 2014 | 0.3424 |
| June 30, 2014 | 0.4149 |
| March 31, 2014 | -0.2545 |
| December 31, 2013 | 0.5835 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | -0.0184 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Santen Pharmaceutical Co., Ltd. | 0.3043 |
| Ono Pharmaceutical Co., Ltd. | 0.0036 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -154.60M |
| Revenue (Quarterly) | 6.976B |
| Total Expenses (Quarterly) | 7.131B |
| Enterprise Value | 76.40B |
| Gross Profit Margin (Quarterly) | 48.79% |
| Profit Margin (Quarterly) | -2.22% |
| Earnings Yield | 2.59% |
| Operating Earnings Yield | 7.28% |